Rituximab therapy for juvenile-onset systemic lupus erythematosus.
about
Rituximab for treating inhibitors in people with inherited severe hemophiliaRituximab for treating inhibitors in children with hemophiliaA treatment algorithm for children with lupus nephritis to prevent developing renal failureSafety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.Anesthetic management of patient with systemic lupus erythematosus and thrombocytopenia for vaginal hysterectomyAutoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureRituximab for the treatment of refractory pediatric autoimmune diseases: a case series.Three decades of progress in treating childhood-onset lupus nephritis.Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysisChildhood- and adult-onset lupus: an update of similarities and differences.Pediatric lupus nephritis: more options, more chances?Reviewing the recommendations for lupus in children.Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.Rituximab for treating inhibitors in people with inherited severe hemophilia.A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran.Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.Complement-4 deficiency in a child with systemic lupus erythematosus presenting with standard treatment-resistant severe skin lesion.[B-cell targeted therapy for children and adolescents with rheumatic diseases].Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.Children and adolescents with SLE: not just little adults.
P2860
Q24186623-A66CABF3-7F28-4050-A714-75C341DC67ABQ24197700-7F4A4A94-9A6D-4B2D-ADBC-4AC5FBF3976DQ27026880-12C09FBF-AB1B-45BB-A38B-E99B69B403BDQ33411406-7CB33B60-5FC7-471F-9AA9-982CC324FE46Q33421410-12FFEBDC-DF8D-44B4-B46F-0AE3AA636D29Q33422111-FA38454A-4B3C-4729-B135-83F2566C81DBQ33601679-F6C09031-9CAD-41CE-9450-43EF84C644B3Q33681901-2ED615D2-BAEC-4342-98AE-83E6C5FBD9F0Q35983508-E0A68335-8446-4774-82D9-90BDAF3E78D8Q36219954-C34AF5AE-2F66-42BE-8B90-8D7B5C3B2528Q37754678-0B38F427-7B3B-46B0-BC7C-23B643512B1DQ38102946-E8535AED-00A1-459B-8D6F-0EEF74DE66E3Q38374309-1B1842BB-5525-41BB-BA36-1885D0A8A997Q38638596-74430F77-2D18-4658-AB7A-0CBE2D600A55Q38661525-B84ACEB5-CA32-4878-B04B-03297BCA2830Q38831835-20977B5A-58CA-4555-B0FB-6DDC443A1BDAQ39160729-7948784D-6F09-4CEE-BAC6-41AE669FF5B2Q41956499-4C2CDC71-D459-43E0-957D-56875F73EA41Q43687687-D232D9A5-B22F-49A9-B7D7-6529AD69A9F0Q46076323-95369F53-D9C1-4ABB-B4CA-64663BED91D3Q51196776-FFEA6A90-6D68-4E33-ADC5-C6D72FD215B3
P2860
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@ast
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@en
type
label
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@ast
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@en
prefLabel
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@ast
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@en
P2093
P2860
P1433
P1476
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
@en
P2093
Carolyn L Abitbol
Gastón Zilleruelo
Jayanthi Chandar
Obioma Nwobi
Wacharee Seeherunvong
P2860
P2888
P304
P356
10.1007/S00467-007-0694-9
P577
2007-12-19T00:00:00Z